Hantaviruses are rodent-borne viruses. They may cause severe diseases with potential risks of human-to-human transmission via body fluids or droplets. Eliminating or minimising contact with rodents is the best way to prevent infection.
Hantaviruses are rodent-borne viruses can be transmitted to humans by contact with faeces/urine from infected rodents or with dust containing infective particles. They may cause severe diseases. Eliminating contact with rodents is the best way to prevent infection.
Immunisation is the only effective method of prevention. Mumps vaccine is given in the form of the combined trivalent measles-mumps-rubella (MMR) vaccine in all European countries with a first dose at or before 18 months of age. The timing of the second dose varies across countries.
ECDC promotes the performance of external quality assessment (EQA) schemes, in which laboratories are sent simulated clinical specimens or bacterial isolates for testing by routine or reference laboratory methods. EQA schemes, or laboratory proficiency testing, provide information about the accuracy of different characterisation and typing methods as well as antimicrobial susceptibility testing (AST) and the sensitivity of the methods in place to detect a certain pathogen or novel resistance patterns.
Annual Epidemiological Report on the Hantavirus infection, 2014. ECDC’s annual surveillance reports provide a wealth of epidemiological data to support decision-making at the national level. They are mainly intended for public health professionals and policymakers involved in disease prevention and control programmes.
In 2014, 2 760 confirmed cases of invasive meningococcal disease were reported to TESSy. The notification rate was 0.5 cases per 100 000 population, which is lower than in previous years.